Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

Siemens Healthineers is positioning itself to benefit from the growing demand for theranostics by partnering with healthcare providers to provide more than equipment. Theranostics, which combines ...

B. Riley initiated coverage of Radiopharm Theranostic (RADX) with a Buy rating and $15 price target Radiopharm in-licenses and incubates ...

This year, the Outpatient Theranostics Center at UCLA Health celebrates its first anniversary of many. UCLA Health is celebrating one year of treating patients with advanced prostate, thyroid and ...

Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, ...

Established in 2022, the Lancet Oncology Commission on Radiotherapy and Theranostics was led by the IAEA and includes experts from 44 academic institutions and medical centres across 23 different ...

Radiopharm Theranostics (ASX:RAD; NASDAQ:RADX, “Radiopharm” or the “Company”), a clinical-stage biopharmaceut ...

Radiopharm Theranostics is a clinical stage radiotherapeutics ... since November 2021. The company has a pipeline of six distinct and highly differentiated platform technologies spanning peptides ...